| Aug 28 |
Viking Therapeutics to Participate at Morgan Stanley 22nd Annual Global Healthcare Conference
|
| Aug 28 |
Eli Lilly Launches Discounted Versions of Obesity Drug Zepbound
|
| Aug 28 |
Why Viking Therapeutics Stock Price Moved Down 6% on Tuesday
|
| Aug 28 |
Viking Therapeutics, Inc. (VKTX): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
|
| Aug 27 |
Why Viking Therapeutics Stock Got Thrashed on Tuesday
|
| Aug 27 |
Weight loss drug developers slump as Eli Lilly slashes cost of some Zepbound doses
|
| Aug 27 |
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
|
| Aug 27 |
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet
|
| Aug 26 |
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
|
| Aug 26 |
Viking Therapeutics Stock Could Rocket 76% Higher According to Wall Street. Is It a Buy Now?
|
